News Quantified

HROW – harrow health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story [Yahoo! Finance]

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS [Seeking Alpha]

Harrow to Present at Two Investor Conferences in December

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

Harrow (NASDAQ:HROW) had its price target raised by analysts at LADENBURG THALM/SH SH from $64.00 to $66.00. They now have a "buy" rating on the stock.

13.5%

BEAT

6.1%

BEAT

3.4%

MISS

Ladenburg Thalmann

Cantor Fitzgerald

Form 8-K HARROW, INC. For: Nov 17

Form 10-Q HARROW, INC. For: Sep 30

Form 8-K HARROW, INC. For: Aug 11

Form 3 HARROW, INC. For: Oct 06 Filed by: Mullery Francis William Jr

Form 25-NSE HARROW, INC. Filed by: Nasdaq Stock Market LLC

Top News Gainers

11/13 Q3/2019 9/30/2019 EPS -0.450 ZacksConsensus -0.020 ActVsEst (0.430) - Miss 23.5%

3/13 Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders 17.2%

3/24 ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services 9.7%

8/15 SHAREHOLDER ALERT: Investigation of Harrow Health Announced by Holzer & Holzer, LLC 8.8%

5/9 Harrow Health Announces First Quarter 2019 Financial Results 8.2%

5/15 Harrow Health (NASDAQ: HROW) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.9%

9/5 Form 8-K HARROW HEALTH, INC. For: Sep 05 7.1%

5/12 Harrow Health, Inc. (HROW) CEO Mark Baum on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.2%

6/25 Harrow Health Adds Two Senior Executives to its Nashville Team 5.2%

3/3 ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA) 4.1%

Top News Decliners

8/14 Form 4 HARROW HEALTH, INC. For: Aug 12 Filed by: Kammer Robert J -24.8%

3/16 Harrow Health (NASDAQ: HROW) had its price target lowered by analysts at B. Riley from $12.75 to $12.00. They now have a "buy" rating on the stock. -24.3%

3/12 ImprimisRx® Announces Supply Agreement with EyeCare Services Partners -15.0%

5/17 Form 8-K HARROW HEALTH, INC. For: May 16 -9.3%

6/28 Form 4 HARROW HEALTH, INC. For: Jun 26 Filed by: AUSTIN STEPHEN G -8.6%

8/30 Form 8-K HARROW HEALTH, INC. For: Aug 27 -7.5%

12/11 Form 8-K HARROW HEALTH, INC. For: Dec 11 -5.7%

12/4 Harrow Health (NASDAQ: HROW) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -5.2%

4/24 Form DEF 14A HARROW HEALTH, INC. For: Apr 24 -4.8%

3/9 ImprimisRx® Announces Supply Agreement with iOR Partners -4.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day